Tag Archives: biopharma
At the end of summer we told you all about a new initiative of the National Brain Tumor Society called the Clinical Trial Endpoints Initiative. At the time we were just getting back from an extremely fruitful meeting with the U.S. Food & Drug Administration (FDA), which set the stage for two upcoming workshops with [...]
The Society for Neuro-Oncology (SNO), the preeminent trade organization for those working in the brain tumor arena, seeks to advance the field through research and education. SNO hosts an annual multi-day meeting that is ‘must-go’ for brain cancer researchers, clinicians, surgeons, patient advocacy organizations, and biopharma industry executives
National Brain Tumor Society staff and advisors recently met with the U.S. Food and Drug Administration (FDA) to discuss how various stakeholders in brain tumor drug development could work together to increase the volume and speed of approvals for new treatments for this disease.